224 related articles for article (PubMed ID: 16640652)
1. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Wilson J; Shaw CA
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):341-3. PubMed ID: 16640652
[No Abstract] [Full Text] [Related]
2. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Cox PA; Banack S; Murch S; Sacks O
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):679-82. PubMed ID: 17083482
[No Abstract] [Full Text] [Related]
3. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
4. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Steele JC; McGeer PL
Neurology; 2008 May; 70(21):1984-90. PubMed ID: 18490618
[TBL] [Abstract][Full Text] [Related]
5. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
[TBL] [Abstract][Full Text] [Related]
6. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Bradley WG; Banack SA; Cox PA
Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
[No Abstract] [Full Text] [Related]
7. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Borenstein AR; Mortimer JA; Schellenberg GD; Galasko D
Neurology; 2009 Feb; 72(5):473, 476; author reply 475-6. PubMed ID: 19188582
[No Abstract] [Full Text] [Related]
8. On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea).
Spencer PS; Palmer VS; Ludolph AC
Mov Disord; 2005 Aug; 20 Suppl 12():S119-26. PubMed ID: 16092101
[TBL] [Abstract][Full Text] [Related]
9. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Cruz-Aguado R; Shaw CA
Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085
[No Abstract] [Full Text] [Related]
10. Toxicology. Fruit bats linked to mystery disease.
Stone R
Science; 2002 Apr; 296(5566):241. PubMed ID: 11951013
[No Abstract] [Full Text] [Related]
11. [Lessons from Guam ALS/PDC study].
Asao H
Rinsho Shinkeigaku; 2007 Nov; 47(11):717-21. PubMed ID: 18210783
[TBL] [Abstract][Full Text] [Related]
12. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
13. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.
Khabazian I; Bains JS; Williams DE; Cheung J; Wilson JM; Pasqualotto BA; Pelech SL; Andersen RJ; Wang YT; Liu L; Nagai A; Kim SU; Craig UK; Shaw CA
J Neurochem; 2002 Aug; 82(3):516-28. PubMed ID: 12153476
[TBL] [Abstract][Full Text] [Related]
14. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.
Schulz JD; Hawkes EL; Shaw CA
Med Hypotheses; 2006; 66(6):1222-6. PubMed ID: 16488551
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
16. [Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam].
Okumura H; Tashiro K
Nihon Rinsho; 2004 Jan; 62 Suppl():136-40. PubMed ID: 15011336
[No Abstract] [Full Text] [Related]
17. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia.
Sundar PD; Yu CE; Sieh W; Steinbart E; Garruto RM; Oyanagi K; Craig UK; Bird TD; Wijsman EM; Galasko DR; Schellenberg GD
Hum Mol Genet; 2007 Feb; 16(3):295-306. PubMed ID: 17185385
[TBL] [Abstract][Full Text] [Related]
18. The nature of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam and magnesium deficiency.
Oyanagi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S17-23. PubMed ID: 15885623
[TBL] [Abstract][Full Text] [Related]
19. Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii peninsula of Japan.
Kokubo Y; Kuzuhara S
Arch Neurol; 2003 Sep; 60(9):1257-61. PubMed ID: 12975292
[TBL] [Abstract][Full Text] [Related]
20. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989.
Waring SC; Esteban-Santillan C; Reed DM; Craig UK; Labarthe DR; Petersen RC; Kurland LT
Neuroepidemiology; 2004; 23(4):192-200. PubMed ID: 15272222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
